Idiopathic Restless Legs Syndrome Clinical Trial
Official title:
Non-Interventional Study (NIS) in Patients With Restless Legs Syndrome (RLS) to Assess the Effectiveness and Safety of Neupro® in Daily Practise
This non-interventional observational study is designed to gain data for Neupro® in restless legs syndrome (RLS) under real life conditions in line with the summary of product characteristics (SmPC) related to effectiveness, tolerability and switching practice from other dopaminergic drugs as well as titration schemes.
There is a total of 64 subjects recorded as having discontinued due to Adverse Events.
Documentation of Visit 2 and Visit 3, where the reason for discontinuation was documented,
was not available for all subjects. From the documentation on the Adverse Events page in the
Case Report Form, it is known that 100 subjects discontinued due to Adverse Events.
The Last Observation Carried Forward (LOCF) method was utilized for all outcomes.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00390689 -
A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.
|
Phase 3 | |
| Completed |
NCT00666965 -
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
|
Phase 2 | |
| Completed |
NCT00498108 -
Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
|
Phase 3 | |
| Completed |
NCT01084551 -
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
|
Phase 3 | |
| Completed |
NCT00806026 -
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
|
Phase 3 | |
| Completed |
NCT01562743 -
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
|
Phase 2 |